- Scrip Originals
Vaxalto Biotherapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Vaxalto Biotherapeutics, Inc.
The center is partnering with Obsidian to make autologous TILs work better after being infused back into patients by using IL-15, which may be less toxic than the high-dose IL-2 currently used.
- Gene Therapy, Cell Therapy
- Large Molecule